Cited by 409Estrogen and related hormone effectsCancer Risks and FactorsMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer

Cauley, Jane A., Lucas, Frances L., Kuller, Lewis H., Stone, Katie, Browner, Warren, Cummings, Steven R., for the Study of Osteoporotic Fractures Research Group·1999·Annals of Internal Medicine

Abstract

BACKGROUND: The relation between endogenous steroid hormones and risk for breast cancer is uncertain. Measurement of sex hormone levels may identify women at high risk for breast cancer who should consider preventive therapies. OBJECTIVE: To test the hypothesis that serum concentrations of estradiol and testosterone predict risk for breast cancer. DESIGN: Prospective case-cohort study. SETTING: Four clinical centers in the United States. PARTICIPANTS: 97 women with confirmed incident breast cancer and 244 randomly selected controls; all women were white, 65 years of age or older, and were not receiving estrogen. MEASUREMENTS: Sex-steroid hormone concentrations were assayed by using serum that was collected at baseline and stored at -190 degrees C. Risk factors for breast cancer were ascertained by questionnaire. Incident cases of breast cancer were confirmed by review of medical records during an average period of 3.2 years. RESULTS: The relative risk for breast cancer in women with the highest concentration of bioavailable estradiol (> or = 6.83 pmol/L or 1.9 pg/mL) was 3.6 (95% CI, 1.3 to 10.0) compared with women with the lowest concentration. The risk for breast cancer in women with the highest concentration of free testosterone compared with those with the lowest concentration was 3.3 (CI, 1.1 to 10.3). The estimated incidence of breast cancer per 1000 person-years was 0.4 (CI, 0.0 to 1.3) in women with the lowest levels of bioavailable estradiol and free testosterone compared with 6.5 (CI, 2.7 to 10.3) in women with the highest concentrations of these hormones. Traditional risk factors for breast cancer were similar in case-patients and controls. Adjustments for these risk factors had little effect on the results. CONCLUSIONS: Estradiol and testosterone levels may play important roles in the development of breast cancer in older women. A single measurement of bioavailable estradiol and free testosterone may be used to estimate a woman's risk for breast cancer. Women identified as being at high risk for breast cancer as determined by these hormone levels may benefit from antiestrogen treatment for primary prevention.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-130-4_part_1-199902160-00004

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 8

  1. Dorgan JF, 1996, Cancer Epidemiol Biomarkers Prev, 5, 533
  2. Helzlsouer KJ, 1994, Cancer Detect Prev, 18, 79
  3. Dorgan JF, 1997, Cancer Epidemiol Biomarkers Prev, 6, 177
  4. 10.1001/jama.1990.03440050059033 · DOI
  5. Armstrong BK, 1981, J Natl Cancer Inst, 67, 761
  6. Rink JD, 1996, J Clin Endocrinol Metab, 81, 2443
  7. Hankinson SE, 1996, Cancer Epidemiol Biomarkers Prev, 4, 649
  8. Muti P, 1996, Cancer Epidemiol Biomarkers Prev, 5, 917

Cited by

Sorted by citations

See all 409

Metadata

Authors
Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., Cummings, S. R., & for the Study of Osteoporotic Fractures Research Group
Affiliations
  • San Francisco VA Medical Center (US)
  • From University of Pittsburgh, Pittsburgh, Pennsylvania; Maine Medical Center, Portland, Maine; University of California, San Francisco; and Veterans Affairs Medical Center, San Francisco, California.
Corresponding author
Cauley, Jane A.
Venue
Annals of Internal Medicine
Published
1999-02-16
Volume
130
Issue
4_Part_1
Pages
270-277
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2026802581
Cited by
409
References
49
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 10 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 11 · 2013: 13 · 2012: 9
FWCI
20.06
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (AM35584)
  • National Institute on Aging (AG-05407)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 35582, R01AR035582)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
breast cancer risk, serum estradiol, free testosterone, sex hormones, bioavailable estradiol, older women, breast cancer incidence, antiestrogen therapy, breast cancer prevention
MeSH terms
Aged, Androstenedione, Breast Neoplasms, Dehydroepiandrosterone, Estradiol, Female, Humans, Prospective Studies, Risk Factors, Testosterone, Incidence, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review